Barroso Osquel, Mazzoni Irene, Rabin Olivier
Science Department, World Anti-Doping Agency (WADA), Montreal, Quebec H4Z 1B7, Canada.
Asian J Androl. 2008 May;10(3):391-402. doi: 10.1111/j.1745-7262.2008.00402.x.
Since ancient times, unethical athletes have attempted to gain an unfair competitive advantage through the use of doping substances. A list of doping substances and methods banned in sports is published yearly by the World Anti-Doping Agency (WADA). A substance or method might be included in the List if it fulfills at least two of the following criteria: enhances sports performance; represents a risk to the athlete's health; or violates the spirit of sports. This list, constantly updated to reflect new developments in the pharmaceutical industry as well as doping trends, enumerates the drug types and methods prohibited in and out of competition. Among the substances included are steroidal and peptide hormones and their modulators, stimulants, glucocorticosteroids, beta2-agonists, diuretics and masking agents, narcotics, and cannabinoids. Blood doping, tampering, infusions, and gene doping are examples of prohibited methods indicated on the List. From all these, hormones constitute by far the highest number of adverse analytical findings reported by antidoping laboratories. Although to date most are due to anabolic steroids, the advent of molecular biology techniques has made recombinant peptide hormones readily available. These substances are gradually changing the landscape of doping trends. Peptide hormones like erythropoietin (EPO), human growth hormone (hGH), insulin, and insulin-like growth factor I (IGF-I) are presumed to be widely abused for performance enhancement. Furthermore, as there is a paucity of techniques suitable for their detection, peptide hormones are all the more attractive to dishonest athletes. This article will overview the use of hormones as doping substances in sports, focusing mainly on peptide hormones as they represent a pressing challenge to the current fight against doping. Hormones and hormones modulators being developed by the pharmaceutical industry, which could emerge as new doping substances, are also discussed.
自古以来,不道德的运动员就试图通过使用兴奋剂来获得不公平的竞争优势。世界反兴奋剂机构(WADA)每年都会公布一份被禁止在体育赛事中使用的兴奋剂物质和方法清单。一种物质或方法若满足以下至少两条标准,可能会被列入该清单:提高运动成绩;对运动员健康构成风险;或违背体育精神。这份清单会不断更新,以反映制药行业的新进展以及兴奋剂使用趋势,它列举了在比赛期间和非比赛期间被禁止的药物类型和方法。其中包括甾体和肽类激素及其调节剂、兴奋剂、糖皮质激素、β2 激动剂、利尿剂和掩蔽剂、麻醉药品和大麻素。血液兴奋剂、篡改、输液和基因兴奋剂等都是清单中列出的被禁止方法的例子。在所有这些物质中,激素是反兴奋剂实验室报告的阳性检测结果中数量最多的。虽然迄今为止大多数是由于合成代谢类固醇,但分子生物学技术的出现使重组肽类激素变得容易获得。这些物质正在逐渐改变兴奋剂使用趋势的格局。促红细胞生成素(EPO)、人生长激素(hGH)、胰岛素和胰岛素样生长因子 I(IGF-I)等肽类激素被认为被广泛滥用以提高成绩。此外,由于缺乏适合检测它们的技术,肽类激素对不诚实的运动员更具吸引力。本文将概述激素在体育赛事中作为兴奋剂的使用情况,主要关注肽类激素,因为它们对当前的反兴奋剂斗争构成了紧迫挑战。还将讨论制药行业正在研发的可能成为新兴奋剂的激素和激素调节剂。